NASDAQ : JYNT
The Joint Corp. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 7.36 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 100.13M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 95.64M |
| Enterprise Value | 75.52M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 13.61M |
| Shares Outstanding | 13.61M |
| Shares Change (YoY) | -3.17% |
| Shares Change (QoQ) | +0.44% |
| Owned by Insiders (%) | 16.48% |
| Owned by Institutions (%) | 35.65% |
| Float | 6.48M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 27.05 |
| Forward PE | 12.48 |
| PS Ratio | 1.63 |
| Forward PS | 1.54 |
| PB Ratio | 6.06 |
| P/TBV Ratio | 6.03 |
| P/FCF Ratio | 22.62 |
| P/OCF Ratio | 17.76 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 19.88 |
| EV / Sales | 1.29 |
| EV / EBITDA | 18.78 |
| EV / EBIT | 32.53 |
| EV / FCF | 17.86 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.83 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.46 |
| Debt / FCF | 0.48 |
| Interest Coverage | 1,532.63 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 10.62% |
| Return on Assets (ROA) | 2.33% |
| Return on Invested Capital (ROIC) | 6.70% |
| Return on Capital Employed (ROCE) | 8.40% |
| Weighted Average Cost of Capital (WACC) | 10.05% |
| Revenue Per Employee | $177,424 |
| Profits Per Employee | $11,510 |
| Employee Count | 330 |
| Asset Turnover | 0.94 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 34,079 |
| Effective Tax Rate | 1.61% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -13.64% |
| 50-Day Moving Average | 7.79 |
| 200-Day Moving Average | 8.59 |
| Relative Strength Index (RSI) | 38.89 |
| Average Volume (20 Days) | 60,481 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 349,244 |
| Short Previous Month | 405,587 |
| Short % of Shares Out | 2.57% |
| Short % of Float | 5.39% |
| Short Ratio (days to cover) | 3.75 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 58.55M |
| Gross Profit | 47.87M |
| Operating Income | 2.32M |
| Pretax Income | 2.11M |
| Net Income | 3.80M |
| EBITDA | 4.02M |
| EBIT | 2.32M |
| Earnings Per Share (EPS) | $0.26 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 22.16M |
| Total Debt | 2.04M |
| Net Cash | 20.12M |
| Net Cash Per Share | $1.48 |
| Equity (Book Value) | 15.88M |
| Book Value Per Share | 1.16 |
| Working Capital | 19.82M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 5.39M |
| Capital Expenditures | -1.16M |
| Depreciation & Amortization | 1.70M |
| Net Borrowing | n/a |
| Free Cash Flow | 4.23M |
| FCF Per Share | $0.31 |
Margins
| Measure | Value |
|---|
| Gross Margin | 81.76% |
| Operating Margin | 3.97% |
| Pretax Margin | 3.61% |
| Profit Margin | 6.49% |
| EBITDA Margin | 6.87% |
| EBIT Margin | 3.97% |
| FCF Margin | 7.22% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 3.17% |
| Shareholder Yield | 3.17% |
| Earnings Yield | 3.70% |
| FCF Yield | 4.42% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $10.00 |
| Price Target Difference | 42.25% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 6.96% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.43 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |